PAVmed Inc. Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

Stockholders' Equity and Common Stock Purchase Warrants - Schedule of Outstanding Warrants to Purchase Common Stock (Details)

Stockholders' Equity and Common Stock Purchase Warrants - Schedule of Outstanding Warrants to Purchase Common Stock (Details) - $ / shares	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Apr. 05, 2018	Feb. 08, 2018	Jan. 11, 2018
Exercise price per share		$ 5.00
Series Z Warrants [Member]
Warrant issued and outstanding	16,815,039	16,815,039
Exercise price per share			$ 3.00
Series W Warrants [Member]
Warrant issued and outstanding	381,818	381,818
Exercise price per share	$ 5.00	$ 5.00	$ 5.00	$ 2.00	$ 2.00
Series S Warrants [Member]
Warrant issued and outstanding	1,199,383	1,199,383
Exercise price per share	$ 0.01
Warrants [Member]
Warrant issued and outstanding	18,449,240	18,449,240
Exercise price per share	$ 1.57	$ 1.57
Equity Classified Warrants [Member] \| Series Z Warrants [Member]
Warrant issued and outstanding	16,815,039	16,815,039
Exercise price per share	$ 1.60	$ 1.60
Warrant expiration date	Apr. 30, 2024	Apr. 30, 2024
Equity Classified Warrants [Member] \| UPO - Series Z Warrants [Member]
Warrant issued and outstanding	53,000	53,000
Exercise price per share	$ 1.60	$ 1.60
Warrant expiration date	Jan. 31, 2022	Jan. 31, 2022
Equity Classified Warrants [Member] \| Series W Warrants [Member]
Warrant issued and outstanding	381,818	381,818
Exercise price per share	$ 5.00	$ 5.00
Warrant expiration date	Jan. 31, 2022	Jan. 31, 2022
Equity Classified Warrants [Member] \| UPO -Series W Warrants [Member]
Warrant issued and outstanding
Exercise price per share
Warrant expiration date	Jan. 31, 2022	Jan. 31, 2022
Equity Classified Warrants [Member] \| Series S Warrants [Member]
Warrant issued and outstanding	1,199,383	1,199,383
Exercise price per share	$ 0.01	$ 0.01
Warrant expiration date	Jan. 31, 2032	Jan. 31, 2032